MTRY · Monterey Innovation Acquisition Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q2 '23 | Q3 '22 | Q4 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q4 '20 |
|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - |
| Total Operating Expenses | $365.6K | $863.9K | - | $25 | $369.1K | - | $182 | - |
| D&A | - | - | - | - | - | - | - | - |
| Operating Income | ($365.6K) | ($182) | - | ($25) | ($369.1K) | - | - | - |
| Interest Expense | - | - | - | - | - | - | - | - |
| Income Tax | $44.3K | $0 | - | $0 | - | - | - | - |
| Net Income | ($151.5K) | ($420.5K) | - | ($188.9K) | ($357.4K) | - | ($182) | - |
| EPS - Basic | - | - | - | - | - | - | $0.00 | - |
| EPS - Diluted | - | - | - | - | - | - | $0.00 | - |
Balance Sheet
| Line item | Q2 '23 | Q3 '22 | Q4 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q4 '20 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $539.8K | $218.4K | $145.8K | $4.9K | $173.6K | $510.8K | $25.0K | - |
| Accounts Receivable | - | $0 | - | - | - | $30.0K | - | - |
| Inventory | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - |
| Current Assets | $547.8K | $380.0K | $388.8K | $401.1K | $598.7K | $929.7K | $6.8K | - |
| Total Assets | $22.41M | $21.87M | $21.42M | $116.81M | $116.94M | $117.35M | $25.0K | - |
| Current Liabilities | $2.98M | $2.28M | $1.68M | $290.4K | $285.8K | - | $1.0K | - |
| Long-term Debt | - | - | - | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - | $285.8K | - | $1.0K |
| Stockholders' Equity | ($2.47M) | ($1.80M) | ($1.14M) | $372.4K | $561.3K | $918.7K | $24.0K | - |
| Retained Earnings | ($2.47M) | ($2.01M) | ($1.86M) | ($1.13M) | ($941.6K) | ($584.2K) | ($1.2K) | - |
Cash Flow
| Line item | Q2 '23 | Q3 '22 | Q4 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q4 '20 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | ($132.5K) | - | - | $0 | - | $0 | - |
| Investing Cash Flow | - | $0 | - | - | - | - | - | - |
| Financing Cash Flow | - | $443.1K | - | - | $0 | - | $25.0K | - |
| CapEx | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q2 '23 | Q3 '22 | Q4 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q4 '20 |
|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||
| Gross margin | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - |
| Return on assets | -0.7% | -1.9% | - | -0.2% | -0.3% | - | -0.7% | - |
| Return on equity | 6.1% | 23.4% | - | -50.7% | -63.7% | - | -0.8% | - |
| Return on invested capital | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||
| Current ratio | 0.18 | 0.17 | 0.23 | 1.38 | 2.09 | - | 6.84 | - |
| Quick ratio | 0.18 | 0.17 | 0.23 | 1.38 | 2.09 | - | 6.84 | - |
| Cash ratio | 0.18 | 0.10 | 0.09 | 0.02 | 0.61 | - | 25.00 | - |
| Leverage | ||||||||
| Debt / Equity | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - |
| Equity multiplier | -9.06 | -12.18 | -18.76 | 313.65 | 208.35 | 127.74 | 1.04 | - |
| Liabilities / Assets | - | - | - | - | - | 0.00 | - | - |
| Efficiency | ||||||||
| Asset turnover | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - |
| Valuation | ||||||||
| P / E | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| Growth | ||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | -1462320.0% | - | - | - | - | - | - | - |
| Net income growth (YoY) | 19.8% | -230939.0% | - | - | - | - | - | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | - | - | - | - | - | - | - | - |
Peer comparison
Same SIC group: Blank Checks
Comparing Monterey Innovation Acquisition Corp against the 5 most active filers in the same SIC group.